Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine
Public DepositedAdd to collection
You do not have access to any existing collections. You may create a new collection.
Downloadable Content
Download PDFCitation
MLA
Lown, Kenneth S, et al. Role of Intestinal P-glycoprotein (mdr1) In Interpatient Variation In the Oral Bioavailability of Cyclosporine. 1997. https://doi.org/10.17615/wk91-7352APA
Lown, K., Mayo, R., Leichtman, A., Hsiao, H., Turgeon, D., Schmiedlin Ren, P., Brown, M., Guo, W., Rossi, S., Benet, L., & Watkins, P. (1997). Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine. https://doi.org/10.17615/wk91-7352Chicago
Lown, Kenneth S., Robert R Mayo, Alan B Leichtman, Hsiu Ling Hsiao, D. Kim Turgeon, Phyllissa Schmiedlin Ren, Morton B Brown et al. 1997. Role of Intestinal P-Glycoprotein (mdr1) In Interpatient Variation In the Oral Bioavailability of Cyclosporine. https://doi.org/10.17615/wk91-7352- Creator
-
Lown, Kenneth S.
- Other Affiliation: Department of Internal Medicine and the Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan; Department of Biopharmaceutical Sciences, University of California, San Francisco, California, USA
-
Mayo, Robert R.
- Other Affiliation: Department of Internal Medicine and the Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan; Department of Biopharmaceutical Sciences, University of California, San Francisco, California, USA
-
Leichtman, Alan B.
- Other Affiliation: Department of Internal Medicine and the Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan; Department of Biopharmaceutical Sciences, University of California, San Francisco, California, USA
-
Hsiao, Hsiu-ling
- Other Affiliation: Department of Internal Medicine and the Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan; Department of Biopharmaceutical Sciences, University of California, San Francisco, California, USA
-
Turgeon, D. Kim
- Other Affiliation: Department of Internal Medicine and the Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan; Department of Biopharmaceutical Sciences, University of California, San Francisco, California, USA
-
Schmiedlin-Ren, Phyllissa
- Other Affiliation: Department of Internal Medicine and the Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan; Department of Biopharmaceutical Sciences, University of California, San Francisco, California, USA
-
Brown, Morton B.
- Other Affiliation: Department of Internal Medicine and the Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan; Department of Biopharmaceutical Sciences, University of California, San Francisco, California, USA
-
Guo, Wensheng
- Other Affiliation: Department of Internal Medicine and the Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan; Department of Biopharmaceutical Sciences, University of California, San Francisco, California, USA
-
Rossi, Stephen J.
- Other Affiliation: Department of Internal Medicine and the Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan; Department of Biopharmaceutical Sciences, University of California, San Francisco, California, USA
-
Benet, Leslie Z.
- Other Affiliation: Department of Internal Medicine and the Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan; Department of Biopharmaceutical Sciences, University of California, San Francisco, California, USA
-
Watkins, Paul B.
- Other Affiliation: Department of Internal Medicine and the Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan; Department of Biopharmaceutical Sciences, University of California, San Francisco, California, USA
- Abstract
- Interpatient differences in the oral clearance of cyclosporine (INN, ciclosporin) have been partially attributed to variation in the activity of a single liver enzyme termed CYP3A4. Recently it has been shown that small bowel also contains CYP3A4, as well as P‐glycoprotein, a protein able to transport cyclosporine. To assess the importance of these intestinal proteins, the oral pharmacokinetics of cyclosporine were measured in 25 kidney transplant recipients who each had their liver CYP3A4 activity quantitated by the intravenous [14C‐N‐methyl]‐erythromycin breath test and who underwent small bowel biopsy for measurement of CYP3A4 and P‐glycoprotein. Forward multiple regression revealed that 56% (i.e., r2 = 0.56) and 17% of the variability in apparent oral clearance [log (dose/area under the curve)] were accounted for by variation in liver CYP3A4 activity (p less than 0.0001) and intestinal P‐glycoprotein concentration (p = 0.0059), respectively. For peak blood concentration, liver CYP3A4 activity accounted for 32% (p = 0.0002) and P‐glycoprotein accounted for an additional 30% (p = 0.0024) of the variability. Intestinal levels of CYP3A4, which varied tenfold, did not appear to influence any cyclosporine pharmacokinetic parameter examined. We conclude that intestinal P‐glycoprotein plays a significant role in the first‐pass elimination of cyclosporine, presumably by being a rate‐limiting step in absorption. Drug interactions with cyclosporine previously ascribed to intestinal CYP3A4 may instead be mediated by interactions with intestinal P‐glycoprotein.
- Date of publication
- 1997
- DOI
- Identifier
- 2-s2.0-12644272784
- https://doi.org/10.1016/S0009-9236(97)90027-8
- Related resource URL
- Resource type
- Article
- Rights statement
- In Copyright
- Journal title
- Clinical Pharmacology and Therapeutics
- Journal volume
- 62
- Journal issue
- 3
- Page start
- 248
- Page end
- 260
- Language
- English
- Version
- Postprint
- ISSN
- 0009-9236
Relations
- Parents:
This work has no parents.
Items
Thumbnail | Title | Date Uploaded | Visibility | Actions |
---|---|---|---|---|
Role of intestinal Pglycoprotein.pdf | 2019-05-03 | Public | Download |